Methocarbamol NDC 71205-375

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-375Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0375Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-375-20	71205037520	20 TABLET in 1 BOTTLE (71205-375-20)Marketed from Dec 3, 2020
71205-375-30	71205037530	30 TABLET in 1 BOTTLE (71205-375-30)Marketed from Dec 20, 2019
71205-375-60	71205037560	60 TABLET in 1 BOTTLE (71205-375-60)Marketed from Dec 20, 2019
71205-375-90	71205037590	90 TABLET in 1 BOTTLE (71205-375-90)Marketed from Dec 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086989
Marketing start: Dec 15, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 71205-375_0d89910b-e14d-43cb-b669-8f6789efc781SPL ID 0d89910b-e14d-43cb-b669-8f6789efc781SPL set ID 75b964b7-3e76-4460-9777-7656b5daa32eRxCUI 197943UNII 125OD7737X
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205037520 followed by a unit qualifier and the quantity

Package 71205-0375-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 1, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 086989

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 086989
Product	Strength	Form · route	Labeler	Product NDC
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Bryant Ranch Prepack	72162-1363
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Bryant Ranch Prepack	71335-1795
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Bryant Ranch Prepack	63629-1123
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-599